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The cellular uptake and localization characteristics of molecular
probes and therapeutics are fundamental to their efficacy. The rational
construction of molecules with the desired uptake kinetics and
subcellular localization is however not straightforward. Cell-penetrating
peptides (CPPs), such as the HIV Tat peptide and oligoarginine,
promote the cellular uptake of many cargos, including peptides,
proteins, oligonucleotides, plasmids, and peptide nucleic acids.1,2 To
evaluate their entry characteristics, organic fluorophores are routinely
used as the CPP cargo. Some laboratories have varied the fluorophore
to assess uptake and found some fluorophore-dependent changes.3-6
However, uptake of the fluorophore-labeled peptide may not correlate
with that of the free CPP. Here, using a luminescent Ru-octaarginine
conjugate, we explore directly the effects of an attached organic
fluorophore on its cellular uptake and distribution.
Many laboratories are focused on the design of novel metal
complexes as cellular probes and for therapeutic application.7 In our
laboratory, 5,6-chrysenequinone diimine (chrysi) complexes of Rh(III)
are found to selectively inhibit cellular proliferation in mismatch repair-
deficient cells, and these complexes are being explored as potential
chemotherapeutic agents.8 In an effort to target metal complexes to
the nucleus more effectively, we previously prepared a chrysi complex
of Rh(III) covalently tethered to D-octaarginine (D-R8) fluorescein and
found that it rapidly localizes to the nucleus of HeLa cells.9,10 As the
Rh complex itself is not fluorescent, fluorescein was attached to monitor
the subcellular distribution of this Rh-D-R8 conjugate.
We have also carried out studies using dipyridophenazine (dppz)
complexes of Ru(II), which are luminescent, to examine cellular uptake
characteristics of the octahedral transition metal complexes.11 These
dppz complexes serve as light switches for nonaqueous environments,
since hydrogen bonding with water efficiently quenches the Ru
luminescence.12,13 As a result, in aqueous solution, the dppz complexes
luminesce brightly only when bound to DNA or otherwise protected
from water through binding to folded RNAs, or association with
membranes or other macromolecular structures. Dppz complexes of
Ru(II) are able to enter live cells, with uptake by passive diffusion
enhanced by more lipophilic ligands.11 Tris(polypyridyl) complexes
of Ru(II) are furthermore stable to ligand dissociation and substitution.
Thus, as decomposition or loss of ligands would render the Ru complex
nonluminescent, the characteristic luminescence indicates that it
remains intact in the cellular environment.
Here we compare directly cellular uptake by peptide conjugates of
Ru(II) dppz with and without a fluorescent tag. Three Ru(II) dppz
conjugates were synthesized: Ru-octaarginine (Ru-D-R8), Ru-
octaarginine-fluorescein (Ru-D-R8-fluor), and Ru-fluorescein
(Ru-fluor) (Figure 1). Ru(phen)(bpy′)(dppz)2+ was coupled to the
peptide in an analogous manner to that previously described (where
bpy′ ) 4-(3-carboxypropyl)-4′-methyl-2,2′-bipyridine).9,14,15 The com-
plexes were incubated with HeLa cells in complete medium (R-MEM
with 10% FBS) at 37 °C under the following conditions: Ru-D-R8
at 2-20 µM for 30 min, Ru-D-R8-fluor at 2-5 µM for 30 min,
and Ru-fluor at 5 µM for 30 min and 20 µM for 41 h. The samples
were then rinsed with Hanks’ balanced salt solution (HBSS) and
imaged without fixation.16
HeLa cells incubated with Ru-D-R8 at 5 µM for 30 min exhibit
punctate luminescence in the cytoplasm, with complete exclusion from
the nucleus (Figure 1, top). The punctate distribution implicates
endocytosis, a proposed internalization mechanism for oligoarginine
CPPs, as its route into the cell.17 Entrapment in endosomes would
explain the lack of nuclear entry. In this context, the peptide changes
the mode of uptake relative to unconjugated complexes, such as
Ru(phen)(bpy′)(dppz)2+, Ru(phen)2dppz2+, and Ru(bpy)2dppz2+, which
enter by passive diffusion and do not exhibit punctate staining.11 As
expected, for the peptide conjugates, cellular uptake is strongly
enhanced compared to these unconjugated complexes; higher lumi-
nescence is evident in cell samples even after short incubation times.
Notably, increasing the incubation time to 24 h does not change the
subcellular localization of 5 µM Ru-D-R8.
Remarkably, the Ru-octaarginine conjugate containing an appended
fluorescein (Ru-D-R8-fluor) enters the nucleus under the same
incubation conditions for which the complex without fluorescein is
excluded. Ru-D-R8-fluor shows diffuse cytoplasmic and nuclear
fluorescence, strong nucleolar staining, and some punctate cytoplasmic
staining when incubated at 5 µM for 30 min with HeLa (Figure 1,
Figure 1. Typical cellular distribution of Ru conjugates. HeLa cells were
incubated with 5 µM Ru-D-R8 for 30 min (top), 5 µM Ru-D-R8-fluor
for 30 min (middle), or 20 µM Ru-fluor for 41 h (bottom) at 37 °C in
complete medium and then imaged by confocal microscopy. Structures of
conjugates are shown at left. Note that Ru-D-R8 is isolated to the cytoplasm
while Ru-D-R8-fluor stains the cytosol, nucleus, and nucleoli. Ru-fluor
shows only weak cytoplasmic staining. Scale bars are 10 µm. See Supporting
Information for wavelength comparisons.
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center). Some cells have numerous fluorescent punctate structures,
while others have relatively few. The intensity of fluorescence in the
nucleoli is roughly equal to that of these punctate, vesicular structures.
Nucleolar labeling is typical of D-octaarginine, as seen here, although
not of L-octaarginine.18 Notably, at this concentration, D-R8-fluor
and the Rh(III) conjugate of D-R8-fluor also localize to the nucleus.9
Not surprisingly, the Ru-fluorescein conjugate lacking octaarginine
is unable to enter the cell under the same incubation conditions for which
its octaarginine counterparts can translocate (5 µM for 30 min). The
complex is poorly internalized even following a longer incubation time
with higher concentration (20 µM for 41 h) (Figure 1, bottom). Given its
significantly lower positive charge, the complex cannot as effectively use
the membrane potential as a driving force for cellular entry.19
At higher concentrations, the localization of Ru-D-R8 changes
significantly. Up to 10 µM, the complex is restricted to punctate
structures in the cytoplasm. At 15-20 µM, the cell population is
heterogeneous. Some cells have only punctate cytoplasmic staining,
while others exhibit additional diffuse cytoplasmic as well as nuclear
and nucleolar staining (Figure 2). The fraction of cells in the latter
population increases with concentration (Table 1).20 As for Ru-D-
R8-fluor, the nucleolar and punctate staining are of similar intensity,
with fainter nuclear and cytoplasmic staining. A concentration threshold
fordiffusecytoplasmicandnuclear labeling is a featureofoligoarginine-
fluorophore conjugates and has been reported previously.18,20,21 Above
the extracellular threshold concentration, the peptides are postulated
to enter by a nonendocytic mechanism in addition to the endocytic
mechanisms evident at lower concentrations. Markedly, the threshold
for Ru-D-R8-fluor nuclear entry is between 2 and 5 µM, significantly
lower than that for Ru-D-R8.
What role is fluorescein playing in this uptake? Fluorescein, due to
its greater lipophilicity versus the Ru moiety, increases the interaction
of Ru-D-R8-fluor with the cell membrane compared to Ru-D-R8.
This high concentration at the cell surface could facilitate the
nonendocytic uptake mechanism, promoting access to the cytosol and,
ultimately, the nucleus, while low concentrations at the cell surface
should limit the uptake to endocytosis, with consequent endosomal
trapping, observed as punctate cytoplasmic staining.
Thus, as revealed by the luminescent ruthenium cargo, fluorophore
tagging of a cell-penetrating peptide does more than supply lumines-
cence. The molecular nature of the organic fluorophore affects the
transport pathway and its subcellular localization. Hence, the localiza-
tion of the fluorophore-bound peptide cannot simply serve as a proxy
for that of the free peptide.
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Figure 2. Cellular distribution of Ru-D-R8 at higher concentration. HeLa
cells were incubated with 20 µM Ru-D-R8 for 30 min at 37 °C in complete
medium, rinsed with HBSS, and imaged by confocal microscopy. The cells
shown exclude the membrane-impermeable dead cell dye TO-PRO-3. Some
cells have only punctate staining of the cytoplasm (left) while others show
additional staining of the nucleus and nucleoli as well as diffuse cytoplasmic
staining (right). Scale bars are 10 µm.
Table 1. Percentage of HeLa Cells with Nuclear Staining by
Ru-Octaarginine Conjugatesa
Ru conjugate
concn (µM) Ru-D-R8 Ru-D-R8-fluor
2 0% 0%
5 0% 91%
10 0% n.d.
15 38% n.d.
20 60% n.d.
a HeLa cells were incubated with Ru conjugate for 30 min at 37 °C
in complete medium and then rinsed with HBSS and analyzed by
confocal microscopy. ∼50-100 cells were counted for each sample.
Dead cells were excluded by their morphology. Data not determined are
indicated by n.d.
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